According to Hayry et al., Bmi-1 is frequently expressed in gliomas, with a significant correlation between the frequency of Bmi-1 immunoreactive tumour cells and poor survival in grades II–III oligoastrocytomas [181]. This evidence concerns the gene BMI1 and oligoastrocytoma.